Elsevier

The Lancet

Volume 376, Issue 9749, 16–22 October 2010, Page 1302
The Lancet

Correspondence
Can we increase male involvement in AIDS treatment?

https://doi.org/10.1016/S0140-6736(10)61918-6Get rights and content

References (5)

There are more references available in the full text version of this article.

Cited by (13)

  • Dividuality, masculine respectability and reputation: How masculinity affects men's uptake of HIV treatment in rural eastern Uganda

    2013, Social Science and Medicine
    Citation Excerpt :

    Gender equality in access to HIV treatment in high prevalence settings, particularly sub-Saharan Africa (SSA), has attracted significant interest in recent years. Although women in most parts of SSA, and Uganda in particular, still have a higher prevalence of HIV than men (Ministry of Health (MoH) Uganda, ICF International, Calverton Maryland USA, Centers for Disease Control and Prevention Entebbe Uganda, Uganda, U. S. A. f. I. D. K., & WHO Kampala Uganda, 2012; UNAIDS, 2010), there is growing evidence that, once infected, men are more disadvantaged in terms of access to HIV treatment compared to women (Amuron et al., 2007; Birungi & Mills, 2010; Braitstein, Boulle, & Nash, 2008; Muula et al., 2007; Nattrass, 2008). In Uganda, compared to women fewer men are on HIV treatment, they tend to initiate treatment later, are difficult to retain on treatment and have higher mortality on treatment (Alibhai et al., 2010; Kigozi et al., 2009; Lubega et al., 2010; Mermin et al., 2008; Nakigozi et al., 2011).

View all citing articles on Scopus
View full text